HCV clearance patterns in saliva and serum of patients with chronic HCV infection under interferon plus ribavirin therapy

Journal of Oral Pathology and Medicine

Volumn 34, Issue 5, 2005, Pages 308-311

  Diz Dios, Pedro ^a,d   Castro, A ^b   Rodriguez I ^c   Reforma, N G ^a   Castro, M ^a   Eirea, M ^a   Hermida, M ^c  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c Institute of Health Sciences   (Spain)

^d NONE   (Spain)

Author keywords

Hepatitis C virus; Interferon; Saliva

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SERUM; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS HEPATITIS;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MIDDLE AGED; POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL; SALIVA; VIRAL LOAD;

EID: 17144376441     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00290.x     Document Type: Article

References (20)

1. Fried MW, Shindo M, Fong TL, Fox PC, Hoofnagle JH, Bisceglie M. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology 1992; 102: 1306-8.
2. Takamatsu K, Koyanagi Y, Okita K, Yamamoto N. Hepatitis C virus in saliva. Lancet 1990; 336: 1515.
3. Hermida M, Ferreiro MC, Barral S, Laredo R, Castro A, Diz Dios P. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using highly sensitive test. J Virol Methods 2002; 101: 29-35.
4. Mastromatteo AM, Rapaccini GL, Pompili M, et al. Hepatitis C virus infection: other biological fluids than blood may be responsible for intrafamiliar spread. Hepatogastroenterology 2001; 48: 193-6.
5. EASL. International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999; 30: 956-61.
6. Roy KM, Bagg J, Bird GLA, et al. Serological and salivary markers compared with biochemical markers for monitoring Interferon treatment for hepatitis C virus infection. J Med Virol 1995; 47: 429-34.
7. Poynard T, McHutchison J, Goodman Z, Ling MH, Albrecht J. Is an 'à la carte' combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? Hepatology 2000; 31: 211-8.
8. Enriquez J, Gallego A, Torras X, et al. Retreatment for 24 vs. 48 weeks with interferon alfa-2b plus ribavirin of chronic hepatitis C patients who relapsed or did not respond to interferon alone. J Viral Hepat 2000; 7: 403-8.
9. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 1982; 61: 1158-62.
10. Fabris P, Infantolino D, Biasin MR, et al. High prevalence of HCV-RNA in the saliva fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners. Infection 1999; 27: 86-91.
11. Belec L, Legoff J, Si-Mohamed A, et al. Mucosal humoral immune response to hepatitis C virus E1/E2 surface glycoproteins and HCV shedding in saliva and cervicovaginal fluids from chronically infected patients. J Hepatol 2004; 38: 833-42.
12. Roy KM, Bagg J, Follett EA, Brewer A, Lowe GD. Hepatitis C virus in saliva of haemophiliacs patients attending an oral surgery unit. Br J Oral Maxillofac Surg 1996; 34: 162-5.
13. Pawlotsky J, Bouvier-Alias M, Hezode C, Darthuy F, Remire J, Dhumeaux D. Standardization of hepatitis C virus RNA quantification. Hepatology 2000; 32: 654-9.
14. Roy KM, Bagg J, McCarron B. The effect of saliva specimen collection, handling and storage protocols on hepatitis C virus (HCV) RNA detection by PCR. Oral Dis 1999; 5: 123-7.
15. Roy KM, Bagg J, McCarron B, Good T, Cameron S, Pithie A. Predominance of HCV type 2a in saliva from intravenous drug users. J Med Virol 1998; 54: 271-5.
16. Arrieta JJ, Rodríguez-Iñigo E, Ortiz-Movilla N, et al. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001; 158: 259-64.
17. Carrozzo M, Quadri R, Latorre P, et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol 2002; 37: 364-9.
18. Gretch DR, Polyak SJ. (eds) The quasispecies nature of hepatitis C virus: research methods and biological implications. In: Groupe Francais d'Etudes Molèculaires des Hépatites (GEMHEP). Hepatitis C virus: genetic heterogeneity and viral load. Paris, France: John Libbey Eurotext, 1997; 57-69.
19. Zeuzem S, Lee J, Franke A, et al. Quantification of the initial decline of the serum hepatitis C virus RNA and response to interferon alfa. Hepatology 1998; 27: 1149-56.
20. Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Hepatology 2001; 33: 704-7.